Fig. 6From: Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluationsComparison of the impact of annual school-based treatment and community-wide mass treatment on the overall mean worm burden. The scenarios for the relative pre-control burden in adults are shown in Fig. 2 (note they have the same age-weighted overall mean worm burden). The results assume a treatment coverage of 75% and 5% systematic non-complianceBack to article page